PROK יחס מהיר ProKidney Corp.

This price chart for ProKidney Corp. (PROK) illustrates the asset's dynamics, with metrics currently at 8.06. ProKidney Corp. (PROK) invests in the search for treatments for renal pathologies, while high development costs temporarily block operating profit. The business relies on a robust biomaterial transportation system that ensures process stability. The enterprise's success depends on medical breakthroughs, rendering it independent of market cyclicality.

This metric assesses the ability of ProKidney Corp. (PROK) to instantaneously settle short-term debts using cash and accounts receivable, completely excluding illiquid inventories. By analyzing the quick ratio, an investor can identify the financial reserve of ProKidney Corp. (PROK) required to maintain costly express logistics for cellular materials, which confirms the business's operational resilience and minimizes default risk in the event of a sharp decline in inflows.